|
|
Article: Human Genome Sciences Wins Government Deal Worth $165M.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
The federal government agreed to pay $165 million to Human Genome Sciences Inc. under a contract to supply ABthrax (raxibacumab) to the Strategic National Stockpile.
The order calls for 20,000 courses of the therapeutic from the Rockville, Md.-based company, which first must receive licensure under an emergency use authorization before delivering the product. Then it would receive about 90 percent of the total payment. The events are expected concurrently in 2008, and fulfilling the contract's terms would provide HGS its first product sales.
"It's nice to have a top-line number of $165 million," said Andrew McDonald, an ...
Related newspaper, magazine, and journal articles:
|
|
Article: MEGABIOS, GENEMEDICINE AGREE TO `STRATEGIC MERGER' THAT POOLS ...
BIOWORLD Today;
October 27, 1998 ;
700+ words
... ... percent, or $0.281. McGraw told BioWorld Today the move is one of the few "strategic ... into GeneMedicine," Weintraub told BioWorld Today. "This merger allows us to simplify ... up relatively early," Waldron told BioWorld Today. "This merger announcement is the ...
|
|